Ascendis Pharma A/S

ASND

$208.34

Name : Ascendis Pharma A/S

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $12,615,905,280.00

EPSttm : -5.33

Ascendis Pharma A/S

$208.34

1.18%

$2.49

Float Short %

3.81

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

0.9

EPS Last/This Y

5.16

EPS This/Next Y

5.34

Price

211.2

Target Price

244.05

Analyst Recom

Performance Q

25.37

Relative Volume

1.82

Beta

0.43

Ticker: ASND

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	ASND	205.52	0.93	0.35	9918
2025-09-09	ASND	202.84	0.94	0.46	9924
2025-09-10	ASND	198.73	0.97	0.33	10164
2025-09-11	ASND	197.47	0.98	0.05	10149
2025-09-12	ASND	195.52	0.98	0.64	10141
2025-09-15	ASND	196.84	0.98	8.73	10140
2025-09-16	ASND	197.27	1.04	5.50	10438
2025-09-17	ASND	199.59	0.997273081418	0.64320388349515	10254
2025-09-18	ASND	199.35	0.97	0.80	10881
2025-09-19	ASND	197.82	0.96	0.45	11028
2025-09-22	ASND	196.58	0.46	0.38	8336
2025-09-23	ASND	193.81	0.44	4.42	8635
2025-09-24	ASND	193.27	0.45	0.00	8757
2025-09-25	ASND	189.69	0.40	0.02	9461
2025-09-26	ASND	191.61	0.40	0.31	9441
2025-09-29	ASND	191.57	0.39	0.16	9550
2025-09-30	ASND	198.84	0.40	0.02	9556
2025-10-01	ASND	204.23	0.39	0.02	9596
2025-10-02	ASND	201.2	0.39	0.46	9627
2025-10-03	ASND	204.15	0.41	0.09	9996
2025-10-06	ASND	211.01	0.41	0.12	10009
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	ASND	205.22	84.3	420.6	-2.46
2025-09-09	ASND	202.82	83.5	418.9	-2.51
2025-09-10	ASND	198.46	83.5	416.9	-2.51
2025-09-11	ASND	197.67	83.5	420.6	-2.51
2025-09-12	ASND	195.57	83.5	419.2	-2.51
2025-09-15	ASND	194.62	83.5	58.6	-2.51
2025-09-16	ASND	197.24	83.5	426.2	-2.51
2025-09-17	ASND	199.43	83.5	425.8	-2.51
2025-09-18	ASND	199.21	83.5	423.1	-2.51
2025-09-19	ASND	197.70	83.5	422.0	-2.51
2025-09-22	ASND	196.42	83.5	422.4	-2.51
2025-09-23	ASND	194.02	83.5	421.4	-2.51
2025-09-24	ASND	193.28	83.5	423.3	-2.51
2025-09-25	ASND	189.74	83.5	420.3	-2.51
2025-09-26	ASND	191.99	83.5	426.7	-2.51
2025-09-29	ASND	191.54	83.5	423.8	-2.51
2025-09-30	ASND	198.90	83.5	432.2	-2.51
2025-10-01	ASND	204.18	83.5	430.0	-2.51
2025-10-02	ASND	201.04	83.5	421.3	-2.51
2025-10-03	ASND	204.01	83.5	427.6	-2.51
2025-10-06	ASND	211.20	83.5	435.1	-2.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	ASND	0.00	-5.02	4.14
2025-09-09	ASND	0.00	-5.02	4.14
2025-09-10	ASND	0.00	-5.02	4.14
2025-09-11	ASND	0.00	-5.02	4.46
2025-09-12	ASND	0.00	-5.02	4.46
2025-09-15	ASND	0.00	-5.01	4.46
2025-09-16	ASND	0.00	-5.01	4.46
2025-09-17	ASND	0.00	-5.01	4.46
2025-09-18	ASND	0.00	-5.01	4.46
2025-09-19	ASND	0.00	-5.01	4.46
2025-09-22	ASND	0.00	-5.07	4.46
2025-09-23	ASND	0.00	-5.07	4.46
2025-09-24	ASND	0.00	-5.07	4.46
2025-09-25	ASND	0.00	-5.07	3.81
2025-09-26	ASND	0.00	-5.07	3.81
2025-09-29	ASND	0.00	-5.05	3.81
2025-09-30	ASND	0.00	-5.05	3.81
2025-10-01	ASND	0.00	-5.05	3.81
2025-10-02	ASND	0.00	-5.05	3.81
2025-10-03	ASND	0.00	-5.05	3.81
2025-10-06	ASND	0.00	-3.59	3.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.93

Avg. EPS Est. Current Quarter

-0.28

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

-3.59

Beta

0.43

Average Sales Estimate Current Quarter

209

Average Sales Estimate Next Quarter

261

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-1.5

Max Drawdown 5-Year %

-61.7

Target Price

244.05

P/E

Forward P/E

49.76

PEG

P/S

23.88

P/B

P/Free Cash Flow

EPS

-4.97

Average EPS Est. Cur. Y

-2.51

EPS Next Y. (Est.)

2.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-54.94

Relative Volume

1.82

Return on Equity vs Sector %

119.5

Return on Equity vs Industry %

133.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

435.1

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1017

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y